BCG Vaccine

Status
To Patients
Condition
COVID-19
Intervention Type
Intradermal (ID) Injection
Funder Type
Organization | University

Drug Details

BCG, or bacille Calmette-Guerin, is a vaccine for tuberculosis (TB) disease. 

Study Purpose

Bacille Calmette-Guérin (BCG) is a vaccine against tuberculosis, with protective non-specific effects against other respiratory tract infections in in vitro and in vivo studies, and reported morbidity and mortality reductions as high as 70%. Furthermore, in our preliminary analysis, areas with existing BCG vaccination programs appear to have lower incidence and mortality from COVID191. The investigators hypothesize that BCG vaccination can reduce HCW infection and disease severity during the epidemic phase of SARS-CoV-2.

Find a Clinical Trial

 

footer_txt_bblBook a PFF Ambassador for your event.   Call 844.TalkPFF >